Cephalon Loses Bid For Quick Win In Marketing Suit

By Sherry Mazzocchi · March 28, 2011, 7:50 PM EDT

Cephalon Inc. lost a summary judgment bid Wednesday in a Pennsylvania class action claiming the company marketed the cancer pain management drug Actiq for off-label uses and caused third-party payors to...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum and/or Opinion

Case Information

Case Title

EMPLOYERS MUTUAL CASUALTY COMPANY et al v. CEPHALON, INC.

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Other Statutory Actions

Date Filed

October 25, 2007

Recent Articles By Sherry

April 15, 2011
FDA Issues Safety Warning On Teva's Generic Prevacid
April 13, 2011
FDA Warns Philips Over Fatal Defibrillator Defects
April 08, 2011
Nautilus Sues Wockhardt Over Cambia ANDA
April 01, 2011
DOJ Sues Healthpoint Over Zenaderm Marketing
March 25, 2011
Medtronic Unit Must Face Antitrust Claims: Judge
March 25, 2011
Fla. House Committee OKs Malpractice Cap Bill
March 24, 2011
Vermont House Approves Single-Payer Health Care Bill
March 10, 2011
HHS Proposes New State Health Care Waiver Rules
March 07, 2011
BNY, Wells Fargo OK'd To Intervene In $21M Ponzi Deal
March 07, 2011
Gibson Dunn Reps Accuray In $277M Radiotherapy Deal